{"id":"https://openalex.org/W2988024993","doi":null,"title":"Combined use of an ACE-inhibitor and spironolactone in patients with heart insufficiency.","display_name":"Combined use of an ACE-inhibitor and spironolactone in patients with heart insufficiency.","publication_year":2017,"publication_date":"2017-01-01","ids":{"openalex":"https://openalex.org/W2988024993","mag":"2988024993","pmid":"https://pubmed.ncbi.nlm.nih.gov/29952529"},"language":"en","primary_location":{"id":"pmid:29952529","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29952529","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medizinische Monatsschrift fur Pharmazeuten","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080833472","display_name":"Jane Schr\u00f6der","orcid":"https://orcid.org/0000-0002-3833-5143","observed_orcids":["https://orcid.org/0000-0002-3833-5143"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jane Schr\u00f6der","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031129426","display_name":"Lisa Goltz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Goltz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111693599","display_name":"Holger Knoth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Holger Knoth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.3809257,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"40","issue":"1","first_page":"24","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12876","display_name":"Potassium and Related Disorders","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12876","display_name":"Potassium and Related Disorders","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.01730000041425228,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enalapril","display_name":"enalapril","score":0.8420000076293945},{"id":"https://openalex.org/keywords/spironolactone","display_name":"spironolactone","score":1.0},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.7929999828338623},{"id":"https://openalex.org/keywords/hyperkalemia","display_name":"hyperkalemia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.8539999723434448},{"id":"https://openalex.org/keywords/potassium-sparing-agents","display_name":"potassium-sparing agents","score":0.9570000171661377},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7630000114440918},{"id":"https://openalex.org/keywords/serum-potassium-monitoring","display_name":"serum potassium monitoring","score":0.8450000286102295},{"id":"https://openalex.org/keywords/renal-function-monitoring","display_name":"renal function monitoring","score":0.9269999861717224},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.7070000171661377},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.335999995470047},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.9729999899864197}],"concepts":[{"id":"https://openalex.org/C2780243291","wikidata":"https://www.wikidata.org/wiki/Q605259","display_name":"Hyperkalemia","level":2,"score":0.9576126933097839},{"id":"https://openalex.org/C2776379505","wikidata":"https://www.wikidata.org/wiki/Q422188","display_name":"Spironolactone","level":3,"score":0.9334686994552612},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8084211945533752},{"id":"https://openalex.org/C2775940317","wikidata":"https://www.wikidata.org/wiki/Q422185","display_name":"Enalapril","level":4,"score":0.6260361671447754},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.5978103876113892},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5433611869812012},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.49138322472572327},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4753287136554718},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.4600401520729065},{"id":"https://openalex.org/C78085059","wikidata":"https://www.wikidata.org/wiki/Q641303","display_name":"Ejection fraction","level":3,"score":0.4352065920829773},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.14283224940299988},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004232","descriptor_name":"Diuretics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006947","descriptor_name":"Hyperkalemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D013148","descriptor_name":"Spironolactone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013148","descriptor_name":"Spironolactone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:29952529","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29952529","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medizinische Monatsschrift fur Pharmazeuten","raw_type":"Journal Article"},{"id":"mag:2988024993","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29952529","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2076117260","https://openalex.org/W2359800395","https://openalex.org/W2169161789","https://openalex.org/W2080862159","https://openalex.org/W2462370790","https://openalex.org/W2046342099","https://openalex.org/W2123461279","https://openalex.org/W2418241599","https://openalex.org/W2119385077","https://openalex.org/W2408664524"],"abstract_inverted_index":{"A":[0],"patient":[1],"with":[2,86],"cardiac":[3,87],"insufficiency":[4,88],"takes":[5],"the":[6,15,19,65,77,80,98,116,125],"ACE-Inhibitor":[7],"Enalapril":[8],"as":[9,11,148],"well":[10],"Spironolactone":[12],"regularly.":[13],"In":[14],"interaction":[16],"monographs":[17],"of":[18,29,40,58,67,79,95,100,133,150],"German":[20],"ABDA-database":[21],"there":[22,44],"is":[23,43,50,118,139],"a":[24,45],"note":[25],"that":[26,55],"combined":[27,56],"use":[28,57],"these":[30,121],"substances":[31],"should":[32,155],"be":[33,74,156],"avoided":[34],"due":[35],"to":[36,73,76,102],"an":[37,92,103],"increased":[38],"risk":[39,66,71,126,143],"hyperkalemia":[41,146],"\u2013":[42],"medication":[46],"related":[47,75],"problem?":[48],"There":[49],"evidence":[51],"from":[52],"clinical":[53],"studies,":[54],"ACE-inhibitors":[59],"and":[60,91,105,110,136],"potassium-sparing":[61,81],"agents":[62],"indeed":[63],"increases":[64],"severe":[68,128],"hyperkalemia.":[69],"The":[70],"seems":[72],"dose":[78],"agent.":[82],"However,":[83],"in":[84,120],"patients":[85],"NYHA-class":[89],"II-IV":[90],"ejection":[93],"fraction":[94],"\u2264":[96],"35%,":[97],"addition":[99],"spironolactone":[101],"ACE-inhibitor":[104],"betablocking":[106],"agent":[107],"reduces":[108],"mortality":[109],"hospitalization":[111],"for":[112,127,145],"cardiovascular":[113],"problems.":[114],"Therefore":[115],"combination":[117],"indicated":[119],"patients.":[122],"To":[123],"minimize":[124],"adverse":[129],"events":[130],"close":[131],"monitoring":[132],"serum":[134],"potassium":[135,151],"renal":[137],"function":[138],"mandatory.":[140],"Moreover,":[141],"additional":[142],"factors":[144],"such":[147],"intake":[149],"supplements":[152],"or":[153],"NSAID":[154],"avoided.":[157]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-11-22T00:00:00"}